Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

November 30, 2005

Study Completion Date

January 31, 2010

Conditions
Hodgkin's Disease
Interventions
PROCEDURE

Pulmonary Function Tests

Tests include; total lung capacity, vital capacity, functional residual capacity, forced vital capacity, forced expiratory volume in 1 second, carbon monoxide diffusing capacity, pulse oximetry before and after a 6 minute walk and Pulmonary Status and Dyspnea Questionnaire

PROCEDURE

CAT Scan

Obtained at different time points during the study depending upon standard of care chemotherapy treatment

Trial Locations (2)

02115

Brigham and Women's Hospital, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT00165438 - Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy | Biotech Hunter | Biotech Hunter